Scientific Steering Committee
The role of the Scientific Steering Committee has been laid out in the memorandum of understanding of the consortium. This states:
Scientific Steering Committee (SSC)
Membership: This will include representation from all participating cohorts as well as members bringing valuable experience in the disease area, in epidemiological and genetic research, in statistics and methods development. It is envisaged a minimum of one person, usually the PI, will represent each study/cohort.
Responsibilities: The SSC will determine the overall strategic direction of the consortium aiming for transparency, timely communication, effective coordination, and a sharing of responsibilities, challenges, and opportunities among cohort members.
Specifically it will:
- Review, and approve submitted proposals or suggest new proposals, which are in line with the aims and strategic direction of the consortium
- Establish project specific working groups (PSWGs) for each proposal by appointing a Lead to take responsibility for PSWG group composition, contact/ invitation of suitable member cohorts, management and delivery of the aims of the proposal.
- Advise on and approve analytic approaches, optimal study design, publication strategies and authorship criteria for each proposal to the PSWG.
- Advise formation of additional sub-committees as needed, for instance, to harmonize specific endpoints among multiple cohorts
- Determine which funding streams to pursue and how to target these such as creation of grant writing groups as needed.
- Allocate resources when these are available.
- The SSC will meet at approximately bi-monthly intervals (with option for more frequent meetings), led by a chair and a secretary. Quorum will be set at 30%
Membership
Current (2015) steering committee members include:
Study/Cohort Name | Location | SSC Member(s) |
ANGES | Netherlands | Connie Bezzina; AAM Wilde |
ANGES (Finland) | Finland | Leo-Pekka Lyytikainene |
Atheroremo | Netherlands | Patrick Serruys; Eric Boersma |
ATVB | Italy | Diego Ardissino; Nicola Marziliano |
Austrian CAD study | Austria | Heinz Drexel; Christoph Saely |
BHF FHS | UK | Nilesh Samani |
BIOMArCS | Netherlands | Eric Boersma |
CABG Genomics | USA | Jochen Muehlschlegel; Simon Body |
Campania Italia | Italy | Carlo Briguori |
Circulating Cells | Netherlands | I Hoefer |
Cleveland Clinic Genebank | USA | Stan Hazen; Hooman Allayee; Jaana Hartiala |
Clinical Cohorts in Coronary Disease Collaboration (4C) | UK | Harry Hemingway; Riyaz Patel; Aroon Hingorani |
Coronary Disease Cohort Study (CDCS) | New Zealand | Arthur Mark Richards; Vicky Cameron |
Corogene | Finland | Juha Sinisalo |
CURE Genetics Study | Canada | Gui Pare |
Emory Cardiovascular Biobank | USA | Arshed Quyyumi; Riyaz Patel |
ERICO | Brazil | Alexandre Pereira; Paulo Lotufo |
FAST-MI 2005 | France | Tabssome Simon |
FAST-MI 2010 | France | Tabssome Simon |
FRISC II | Sweden, Norway and Denmark | Agneta Siegbahm; Asa Johanssen |
GENDEMIP | Czech | Jaroslav Hubacek |
GENESIS-PRAXY | Canada | Louise Pilote; George Thannasoulis; Jasmine Poole |
GENOCOR | Italy | Clara Carpeggiani; Maria Graza Andreassi; Antonio La’abbte |
GIPS3 | Netherlands | Pim van der Harst |
GoDarts | Scotland | Colin Palmer |
GRACE_Belgium | Belgium | Van De Werf; Diether Lambrechts; Els Wauters |
GRACE_UK | UK | Keith Fox; Kathryn Carruthers |
Icelandic Cath Cohort | Iceland | Anna Helgadottir; Gudmundur Thorgeirsson |
Icelandic MI Cohort | Iceland | Anna Helgadottir |
IDEAL | USA | Benoit Arsenault; Marie-Pierre Dubé |
IHD PEARL | Netherlands | Folkert Asselbergs |
Intermountain Heart Collaborative Study | USA | Jeffrey Anderson; Benjamin Horne |
INVEST-Genes | USA | Julie Johnson; Yan Gong; Rhonda Cooper deHoff |
ISAR Cohort | Germany | Adnan Kastrati; Werner Koch |
Karola Study | Germany | Hermann Brenner; Ute Mons |
LIFE-Heart | Germany | Joachim Thiery; Markus Scholze |
LifeLines | Netherlands | Pim van der Harst |
LURIC | Germany | Winifried Maerz; Marcus Kleber |
Malmo Diet and Cancer Study | Sweden | Gustav Smith |
Nanjin Cohort | China | Lina Wang |
NE Poland Cohort | Poland | Karol Kaminski; Anna Kozaraiadska |
Ottawa Heart Genomics Study | Canada | Rob Roberts; Alex Stewart |
PERGENE/EUROPA | Europe | Eric Boersma |
PLATO | Sweden | Lars Wallentin; Axel Akerblom |
PMI | New Zealand | Arthur Mark Richards; Vicky Cameron |
POPular | Netherlands | JM ten Berg; Thomas Bergmeijer |
POPular-Genetics | Netherlands | JM ten Berg; Thomas Bergmeijer |
PREMIER & INFORM Cohorts | USA | John Spertus; Sharon Cresci; Thomas Morgan |
PREVEND | Netherlands | Pim van der Harst |
PROSPER | Netherlands | Wouter Jukema; Naveed Sattar; Stella Trompet; Iris Postmus |
RISCA | Canada | James Brophy; Peter Bogaty; George Thannasoulis; Jamie Engert |
SMART | Netherlands | Ale Algr; Vinicius Tragante |
STABILITY | Sweden | Lars Wallentin; Axel Akerblom |
Stockholm Heart Epidemiology Program (SHEEP) | Sweden | Ulf De Faire; Karin Leander |
TEXGEN ACS | USA | Christie Ballantyne; Salim Virani |
TEXGEN CABG | USA | Christie Ballantyne; Salim Virani |
The Finnish Cardiovascular Study (FINCAVAS) | Finland | Mika Kahonen; Terho Lehtimaki; Leo-Pekka Lyytikainene |
The Heart & Soul Study | USA | Mary Whooley; Mark Pabst |
TNT | Netherlands | Kees Hovingh |
TRIUMPH | USA | John Spertus; Sharon Cresci; Thomas Morgan |
UCORBIO | Netherlands | Folkert Asselbergs |
Utrecht CV Genetics Study | Netherlands | Anke Hanse Maitland Van Der Zee; Mark de Groot |
Verona Heart Study | Italy | Domenico Girelli; Nicola Martinelli; Oliviero Oliveri |
WARSAW ACS | Poland | Marek Kiliszek |
WARSAW STEMI | Poland | Marek Kiliszek |